IRIS
AUDRITO, VALENTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 444
NA - Nord America 272
AS - Asia 227
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
SA - Sud America 1
Totale 947
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 267
IT - Italia 165
SG - Singapore 117
IE - Irlanda 94
HK - Hong Kong 82
DE - Germania 49
SE - Svezia 26
GB - Regno Unito 23
CN - Cina 19
UA - Ucraina 17
CZ - Repubblica Ceca 16
FI - Finlandia 13
CH - Svizzera 8
NL - Olanda 6
AT - Austria 5
CA - Canada 5
KR - Corea 5
LT - Lituania 5
BE - Belgio 4
ES - Italia 3
GR - Grecia 3
RO - Romania 3
HR - Croazia 2
IN - India 2
AU - Australia 1
BR - Brasile 1
EG - Egitto 1
EU - Europa 1
FR - Francia 1
IL - Israele 1
IQ - Iraq 1
PT - Portogallo 1
Totale 947
Salva come PNG Salva come JPEG
Città #
Dublin 94
Singapore 91
Hong Kong 82
Jacksonville 30
Boardman 26
Turin 23
Milan 22
Vercelli 21
Munich 20
Brno 16
Chandler 16
Dearborn 13
Novara 10
Lawrence 6
London 6
Manchester 6
Princeton 6
Wilmington 6
Beijing 5
Vienna 5
Zurich 5
Amsterdam 4
Bologna 4
Como 4
Frankfurt am Main 4
Rome 4
San Mateo 4
Andover 3
Athens 3
Beauharnois 3
Bern 3
Helsinki 3
Kunming 3
Mülheim 3
Palo Alto 3
Piemonte 3
Santa Clara 3
Truccazzano 3
Alaquàs 2
Bari 2
Brussels 2
Casatenovo 2
Catania 2
Croydon 2
Genoa 2
Kensington 2
Mobile 2
Modena 2
New York 2
Nichelino 2
Nuremberg 2
Oleggio 2
Philadelphia 2
Pollenza 2
Rapallo 2
Rockville 2
Tomball 2
Toronto 2
Ulsan 2
Zagreb 2
Ann Arbor 1
Ashburn 1
Balasore 1
Bethesda 1
Brisbane 1
Buffalo 1
Cairo 1
Chengdu 1
Chicago 1
Chongqing 1
Cuorgnè 1
Edinburgh 1
Fairfield 1
Floreşti 1
Ghent 1
Hefei 1
Horia 1
Houston 1
Kirkuk 1
Leuven 1
Los Angeles 1
Madrid 1
Mishmarot 1
Nanjing 1
Naples 1
Noicattaro 1
Norwalk 1
Portland 1
Porto 1
Regensburg 1
Stockholm 1
Suwon 1
São Paulo 1
Tenhult 1
Terranuova Bracciolini 1
Tower Hamlets 1
Trecate 1
Totale 647
Salva come PNG Salva come JPEG
Nome #
Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia. 61
A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment 59
HLA-G IS A COMPONENT OF THE CLL ESCAPE REPERTOIRE TO GENERATE IMMUNE SUPPRESSION: IMPACT OF HLA-G 14 BP (RS66554220) POLYMORPHISM 49
Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network 43
SLAMF1 regulation of chemotaxis and autophagy determines CLL patient response 39
Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma 39
A Selective ALDH1A3 Inhibitor Impairs Mesothelioma 3-D Multicellular Spheroid Growth and Neutrophil Recruitment 36
NAMPT in drug-resistant melanoma: linking NAMPT-dependent metabolic reprogramming and immune regulation 36
Bi-directional crosstalk between NAD/NAMPT and IFN-γ/PD-L1axes in melanoma 33
Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma 28
P13-17: Effect of Ether Perfluoro Carboxyl Acid (PFAS) on Innate Immunity in Earthworms 28
Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed and abundantly released from malignant pleural mesothelioma cells becoming a potential biomarker. 23
NAD/NAMPT and mTOR Pathways in Melanoma: Drivers of Drug Resistance and Prospective Therapeutic Targets 22
RICTOR/mTORC2 downregulation in BRAFV600E melanoma cells promotes resistance to BRAF/MEK inhibition 21
Procedimento immunologico e kit per la diagnosi in vitro di patologie tumorali e/o infiammatorie 20
Protective Role of the M-Sec-Tunneling Nanotube System in Podocytes 20
Immunological method and kit for in vitro diagnosis of tumor and/or inflammatory diseases 18
NAMPT inhibition impairs mTOR-dependent regulation of translation in melanomaNAMPT inhibition impairs mTOR-dependent regulation of translation in melanoma. 17
Adenosine Signaling Mediates Hypoxic Responses in the Chronic Lymphocytic Leukemia Microenvironment 16
The hidden life of NAD+-consuming ectoenzymes in the endocrine system 15
Extracellular nicotinate phosphoribosyltransferasebinds Toll like receptor 4 and mediatesinflammation 15
Tumors carrying BRAF-mutations over-express NAMPT that is genetically amplified and possesses oncogenic properties 15
The Role of the Toll-like Receptor 2 and the cGAS-STING Pathways in Breast Cancer: Friends or Foes? 14
Investigating the presence of eNAMPT/visfatin in human skimmed milk and milk fat globule membrane before and after Holder pasteurization. 14
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 14
Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironment 13
CD38 in chronic lymphocytic leukemia: from bench to bedside? 13
Extracellular Nicotinamide Phosphoribosyltransferase (NAMPT) Shapes the CLL Microenvironment Promoting Macrophage M2 Polarization Via a Non-Enzymatic Mechanism 12
Targeting metabolic reprogramming in metastatic melanoma: The key role of nicotinamide phosphoribosyltransferase (NAMPT) 12
DIFFERENT AQUAPORIN-4 EXPRESSION IN GLIOBLASTOMA MULTIFORME PATIENTS WITH AND WITHOUT SEIZURES 12
Abstract 2302: The extracellular form of NAMPT contributes to creating a proinflammatory environment in chronic lymphocytic leukemia 11
BRAF-mediated NAMPT overexpression induces a melanoma cell dedifferentiation program leading to metabolic reprogramming and intrinsic resistant to BRAF inhibitors 11
Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) is a novel marker for patients with BRAF-mutated metastatic melanoma 11
IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies 11
Metabolic adaptation in colorectal cancer: heme export is required for the down-modulation of the tricarboxylic acid cycle 11
The heme synthesis-export system regulates the tricarboxylic acid cycle flux and oxidative phosphorylation 11
Abstract 5170: Metabolism and cancer: The CD38-NAMPT connection in chronic lymphocytic leukemia 10
Metabolic adaptation in colorectal cancer: heme export is required for the down-modulation of the tricarboxylic acid cycle 9
The heme biosynthesis-heme export axis is required for the modulation of the tricarboxylic acid cycle 9
Abstract 2630: Nicotinamide activates the p53/miR-34a/SIRT1 tumor suppressor network leading to apoptosis of chronic lymphocytic leukemia cells 9
Loss of the heme exporter FLVCR1a impairs mitochondrial functionality: a new approach against colorectal cancer 8
The heme exporter FLVCR1a modulates the tricarboxylic acid cycle: a new target in colorectal cancer 8
The dual face of NAMPT: Intracellular/extracellular protein and diagnostic/therapeutic target in cancer 8
NAMPT and NAPRT: Two Metabolic Enzymes With Key Roles in Inflammation 7
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death 7
NAMPT: A critical driver and therapeutic target for cancer 7
Molecular insights into the interaction between human nicotinamide phosphoribosyltransferase and Toll-like receptor 4 7
Targeting the microenvironment in chronic lymphocytic leukemia offers novel therapeutic options 7
miRNA-guided reprogramming of glucose and glutamine metabolism and its impact on cell adhesion/migration during solid tumor progression 6
Metabolic adaptation in colorectal cancer: heme export is required for the modulation of the tricarboxylic acid cycle 6
PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p 6
NAD+-metabolizing ecto-enzymes shape tumor-host interactions: the chronic lymphocytic leukemia model 6
Metabolic Interplay between the Immune System and Melanoma Cells: Therapeutic Implications 6
Vitamin C Restricts the Emergence of Acquired Resistance to EGFR-Targeted Therapies in Colorectal Cancer 6
Nampt over-expression recapitulates the braf inhibitor resistant phenotype plasticity in melanoma 5
Targeting mitochondria by ss-31 ameliorates the whole body energy status in cancer-and chemotherapy-induced cachexia 5
PD-L1 marks a subset of melanomas with a shorter overall survival and distinct genetic and morphological characteristics 5
Impact of Holder pasteurization on protein and eNAMPT/Visfatin content in human breast milk 5
TBC1 domain-containing proteins are frequently involved in triple-negative breast cancers in connection with the induction of a glycolytic phenotype 4
Targeting the Adenosinergic Axis in the Eμ-TCL1 Chronic Lymphocytic Leukemia Mouse Model Offers Novel Therapeutic Opportunities 4
Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma 4
The enzymatic activities of CD38 enhance CLL growth and trafficking: implications for therapeutic targeting 4
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia 4
NAD-Biosynthetic and Consuming Enzymes as Central Players of Metabolic Regulation of Innate and Adaptive Immune Responses in Cancer 3
Subcellular characterization of NAD+ biosynthesis in metastatic melanoma by using organelle-specific biosensors 3
The Extracellular NADome Modulates Immune Responses 3
SLAMF1/CD150 Activates Autophagy in Chronic Lymphocytic Leukemia Cells, Modulating Chemotaxis and Responses to Therapy 3
Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma 3
Multiple metamorphoses of CD38 from prognostic marker to disease modifier to therapeutic target in chronic lymphocytic leukemia 3
Pancreatic cancer immune evasion mechanisms: the immunosuppressive role of P2RX1-negative neutrophils 3
Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma 3
Regulation Of CLL Growth and Trafficking By The Enzymatic Functions Of CD38: Implications For Therapeutic Targeting 2
SLAMF1/CD150 IS A SIGNALING RECEPTOR EXPRESSED BY A SUBSET OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS CHARACTERIZED BY A FAVORABLE PROGNOSIS 2
Slamf-1/CD150 Is a Signaling Receptor Expressed by a Subset of Chronic Lymphocytic Leukemia Patients Characterized by a Favorable Prognosis 2
The status of PD-L1 and tumor-infiltrating immune cells predict resistance and poor prognosis in BRAFi-treated melanoma patients harboring mutant BRAFV600 2
Totale 1.027
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.694
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.694
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202038 0 0 0 0 0 8 12 4 5 3 6 0
2020/202131 5 0 5 0 5 0 5 1 5 0 5 0
2021/202228 0 0 4 1 1 0 2 2 1 5 4 8
2022/2023197 6 5 7 2 3 17 3 12 119 6 9 8
2023/2024389 13 26 32 18 62 4 86 33 6 5 22 82
2024/2025299 46 5 119 34 92 3 0 0 0 0 0 0
Totale 1.027